Clinical Trials Directory

Trials / Completed

CompletedNCT05940649

Continuous Versus Bolus Administration of Norepinephrine to Treat Hypotension During Anesthetic Induction

Continuous Versus Bolus Administration of Norepinephrine to Treat Hypotension During Anesthetic Induction - the INDUCT Randomized Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
262 (actual)
Sponsor
Kristen Thomsen · Academic / Other
Sex
All
Age
45 Years
Healthy volunteers
Not accepted

Summary

Intraoperative hypotension is common in patients having non-cardiac surgery with general anesthesia and is associated with organ injury and death. The timely treatment of intraoperative hypotension is thus important to avoid postoperative complications. About one third of intraoperative hypotension occurs during anesthetic induction - i.e., between the start of anesthetic induction and surgical incision. Hypotension during anesthetic induction is associated with postoperative acute kidney injury. Unmodifiable risk factors for hypotension during anesthetic induction include age, male sex, and a high American Society of Anesthesiologists physical status class. However, hypotension during anesthetic induction is mainly driven by modifiable factors - specifically, anesthetic drugs that cause vasodilation. In most German hospitals, norepinephrine is the first-line vasopressor to treat hypotension during anesthetic induction. Norepinephrine is usually given as repeated manual boluses of 5, 10, or 20 μg. The continuous administration of norepinephrine via a perfusion pump is usually started only later. It remains unknown whether giving norepinephrine continuously - compared to giving it as repeated manual boluses - reduces hypotension during anesthetic induction. We thus propose to investigate whether giving norepinephrine continuously - compared to giving it as repeated manual boluses - reduces hypotension during anesthetic induction in non-cardiac surgery patients.

Conditions

Interventions

TypeNameDescription
PROCEDUREContinuous norepinephrine administrationIn patients randomized to continuous norepinephrine administration, hypotension (= mean arterial pressure \< 65mmHg) will be treated with continuous norepinephrine infusion. The norepinephrine perfusion line will be connected to the saline infusion line using a three-way valve. Treating anesthesiologists will be free to reduce or increase the norepinephrine infusion rate anytime.

Timeline

Start date
2023-07-03
Primary completion
2024-06-06
Completion
2024-07-01
First posted
2023-07-11
Last updated
2024-11-15

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT05940649. Inclusion in this directory is not an endorsement.